Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2025-01-05T12:20:38.489Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of Epilepsy in Drug-Resistant Patients

Published online by Cambridge University Press:  07 November 2014

Brien J. Smith  and
Andrew J. Cole
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Expert Review Supplement
Information
CNS Spectrums , Volume 15 , Issue S2 , January 2010 , pp. 3 - 6
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kwan, P, Brodie, MJ. Early identification of refractory epilepsy. N Engl J Med. 2000: 342(5): 314–319CrossRefGoogle ScholarPubMed
2. Schmidt, D, Stavem, K. Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: A review of controlled studies. Epilepsia. 2009: 50(6): 1301–1309.CrossRefGoogle ScholarPubMed
3. Kwan, P, Arzimanoglou, A, Berg, AT et al. . Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. In press.Google Scholar
4. Engel, J Jr.Finally, a randomized controlled trial of epilepsy surgery. N Engl J Med. 2001: 345(5): 365–367.CrossRefGoogle ScholarPubMed
5. Berg, ATLangfitt, JShinnar, S et al. . How long does it take for partial epilepsy to become intractable? Neurology. 2003: 60(2): 186–190.CrossRefGoogle ScholarPubMed
6. Morrell, F, Secondary epileptogenesis in man. Arch Neurol. 1985: 42(4): 318–335.CrossRefGoogle ScholarPubMed
7. Lüders, HO. Clinical evidence for secondary epileptogenesis. In: Lowenstein, DH. ed. Brain Plasticity and Epilepsy. San Diego, CA: Academic Press: 2001: 469–480.CrossRefGoogle Scholar
8. Shorvon, SD, Reynolds, EH. Reduction in polypharmacy for epilepsy. Br Med J. 1979: 2(6197): 1023–1025.CrossRefGoogle ScholarPubMed
9. Schmidt, D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia. 1983: 24(3): 368–376.CrossRefGoogle ScholarPubMed
10. French, JA, Faught, E.Rational polytherapy. Epilepsia. 2009: 50(suppl. 8): 63–68.CrossRefGoogle ScholarPubMed
11. Ferrendelli, JA. Relating pharmacology to clinical practice: the pharmacologic basis of rational polypharmacy. Neurology 1995: 45(3 suppl 2): S12–S16.Google ScholarPubMed
12. Cramer, JA, Ben Menachem, E, French, J. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res. 2001: 47(1–2): 17–25.CrossRefGoogle ScholarPubMed
13. Ben-Menachem, E. Strategy for utilization of new antiepileptic drugs. Curr Opin Neurol. 2008: 21(2): 167–172.CrossRefGoogle ScholarPubMed
14. White, HS, Smith, MD, Wilcox, KS. Mechanisms of action of antiepileptic drugs. Int Rev Neurobiol. 2007: 81: 85–110.CrossRefGoogle ScholarPubMed
15. French, JA, Gidal, BE. Antiepileptic drug interactions. Epilepsia. 2000: 41(suppl 8): S30–S36.CrossRefGoogle ScholarPubMed
16. Abou-Khalil, BW. Lacosamide: What can be expected from the next new antiepileptic drug? Epilepsy Curr. 2009: 9(5): 133–134.CrossRefGoogle ScholarPubMed
17. Lacosamide [package insert] Smyrna, GA: UCB Pharma: 2008.Google Scholar
18. Jung, MF, Lippert, B, Metcalf, BW, Bohlen, P, Schechter, PJ. gamma-Vinyl GABA (4-amino-hex 5-enoic acid), a new selective irreversible inhibitor of GABA-T:effects on brain GABA metabolism in mice. J Neurochem. 1977: 29(5): 797–802.CrossRefGoogle ScholarPubMed
19. Vigabatrin [package insert]. Deerfield, IL: Lundbeck: 2009.Google Scholar
20. Michael, B, Marson, AG. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev. 2008: (2): CD004154.Google Scholar
21. Landmark, CJ, Johannesses, SI. Pharmacological management of epilepsy; Recent advances and future prospects. Drugs. 2008: 68(14): 1925–1939.CrossRefGoogle Scholar
22. Kossoff, EH, Rowley, H, Sinha, SR, Vining, EPG. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008: 49(2): 316–319.CrossRefGoogle ScholarPubMed
23. Sirven, JI, Berg, AT. Marijuana as a treatment for epilepsy and multiple sclerosis? A “grass roots” movement. Neurology. 2004: 62(11): 1924–1925.CrossRefGoogle ScholarPubMed
24. Gordon, E, Devinsky, O. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia. 2001: 42(10): 1266–1272.CrossRefGoogle ScholarPubMed
25. Gross, DW, Hamm, J, Ashworth, NL, Quigley, D. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology. 2004: 62(11): 2095–2097.CrossRefGoogle ScholarPubMed
26. Balabanov, A, Rossi, MA. Epilepsy surgery and vagal nerve stimulation: what all neurologists should know. Semin Neurol. 2008: 28(3): 355–363.CrossRefGoogle ScholarPubMed
27. Boon, P, Raedt, R, de Herdt, V, Wyckhuys, T, Vonck, K. Electrical stimulation for the treatment of epilepsy. Neurotherapeutics. 2009: 6(2): 218–227.CrossRefGoogle ScholarPubMed
28. Alsaadi, TM, Laxer, KD, Barbara, NM Jr, Marks, WJ, Garcia, PA. Vagus nerve stimulation for the treatment of bilateral independent temporal lobe epilepsy. Epilepsia. 2001: 42(7): 954–956.CrossRefGoogle ScholarPubMed
29. Fisher, RS. Non-pharmacological approach: release of the “Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy (SANTE)” trial results. Paper presented at: the 62nd Annual Meeting of the American Epilepsy Society; December 5–9. 2008: Seattle, WA.Google Scholar
30. Morrell, MJ and the RNS System Pivotal Investigators. Results of a multicenter double blinded randomized controlled pivotal investigation of the RNS System for treatment of intractable partial epilepsy in adults. Abstract presented at: the 63nd Annual Meeting of the American Epilepsy Society: December 6–8. 2009: Boston, MA.Google Scholar
31. Régis, J, Rey, M, Bartolomei, F et al. . Gamma knife surgery for mesial temporal lobe epilepsy. Epilepsia. 1999: 40(11): 1551–1556.CrossRefGoogle ScholarPubMed
32. Barbaro, NM, Quigg, M, Broshek, DK et al. . A multicenter, prospective pilot study of gamma knife radiosurgery for mesial temporal lobe epilepsy: seizure response, adverse events, and verbal memory. Ann Neurol. 2009: 65(2): 167–175.CrossRefGoogle ScholarPubMed
33. Behrens, E, Schramm, J, Zentner, J, Konig, R. Surgical and neurological complications in a series of 708 epilepsy surgery procedures. Neurosurgery. 1997: 41(1): 1–9.CrossRefGoogle Scholar
34. Spencer, SS. Gamma knife radiosurgery for refractory medial temporal lobe epilepsy. Too little, too late? Neurology. 2008: 70(19): 1654–1655.CrossRefGoogle ScholarPubMed